PREVALENCE AND ANTIBIOTIC SUSCEPTIBILITY OFSTAPHYLOCOCCUS AUREUS IN ICU BLOOD
Keywords:
Staphylococcus aureus, ICU bloodstream infections, Antibiotic susceptibility, MRSA, Antimicrobial resistance, Blood cultureAbstract
This investigation investigated the drug susceptibility and prevalence of Staphylococcus aureus which were isolated from blood samples in the ICU. Conventional microbiological techniques were employed to analyze blood culture-positive samples for Staphylococcus aureus, and the Kirby–Bauer disk diffusion method was employed to evaluate antibiotic susceptibility in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines. Cefoxitin discs have demonstrated resistance to methicillin. The intensive care unit's predominant bloodstream isolate was Staphylococcus aureus, including MRSA, according to the study. The bacteria were susceptible to vancomycin and linezolid, but they were resistant to penicillin and erythromycin. The critical significance of antibiotic stewardship in intensive care units is underscored by the multidrug resistance of Staphylococcus aureus.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Medical and Pharmaceutical Excellence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Engineering Excellence (JEE) are licensed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Under this license, authors retain full copyright of their work while granting permission for anyone to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or author — provided that the original work is properly cited.
This open-access license ensures maximum dissemination and impact of the published research by allowing free and immediate access to scholarly work.
For more details, please refer to the official license page:
???? https://creativecommons.org/licenses/by/4.0/
